Summary & Overview

CPT 0699T: Posterior Chamber Injection for Therapeutic Ophthalmic Treatment

CPT code 0699T denotes a targeted intraocular procedure in which a clinician injects medication into the posterior chamber of the eye for therapeutic effect. Nationally, this code captures a growing set of ophthalmic interventions used to treat retinal and vitreous diseases that require precise delivery of medications to the posterior segment. Usage of this code matters for clinical coding, facility billing, and payer policy given the specialized setting and procedural resources involved.

Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical purpose and typical settings, plus the types of benchmarks and policy topics often relevant to procedures of this kind: utilization benchmarks, site-of-service considerations, and payer coverage patterns. The publication also summarizes common billing modifiers associated with complex or altered perioperative circumstances and notes where input data was unavailable.

This resource is intended for coding professionals, billing managers, and policy analysts seeking a clear national-level briefing on the clinical and billing context of CPT code 0699T. It frames the essential operational and policy issues without recommending clinical actions.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicare0699TCPTophthalmologyintraocular injectionposterior chamberambulatory surgical centerhospital outpatientprocedural codingophthalmic therapeutics

Billing Code Overview

CPT code 0699T describes an ophthalmic procedure in which the provider injects medication into the posterior chamber of the eye, typically for therapeutic purposes. The service type is an intraocular injection targeted at the posterior segment for treatment of retinal or vitreous conditions. The typical site of service is an ambulatory surgical center or hospital outpatient setting where intraocular procedures are performed under sterile conditions.

Data not available in the input.

Clinical & Coding Specifications

Clinical Context

A 68-year-old patient with neovascular (wet) age-related macular degeneration presents with sudden worsening of central vision and new subretinal fluid on optical coherence tomography (OCT). The ophthalmologist evaluates the posterior segment, confirms active choroidal neovascularization, and determines intravitreal pharmacologic therapy is indicated. In the office-based procedure room under sterile technique, topical anesthesia and antisepsis are applied, and the provider injects medication into the posterior chamber of the eye. Post-injection, the patient is observed briefly for elevated intraocular pressure and instructed on signs of endophthalmitis and follow-up. The workflow includes documentation of informed consent, indication, laterality, medication name and dose, lot numbers, procedure details, and post-procedure instructions; billing uses the procedure code 0699T with appropriate modifier(s) for laterality or special circumstances as applicable.

Coding Specifications

Modifier	Description	When to Use
`50`	Bilateral procedure	Use when injections into both eyes are performed during the same encounter and payer allows bilateral reporting.
`51`

Taxonomy Code	Specialty	Notes
`207W00000X`	Ophthalmology	Retinal specialists and general ophthalmologists commonly perform intravitreal posterior chamber injections.
`207W00000X-RET`	Vitreoretinal Surgery (Retina/Vitreous)	Retinal surgeons performing therapeutic posterior chamber injections for macular disease.
`363A00000X`	Optometry	Some therapeutic injections may be performed by optometrists in states/payer environments where scope allows; check local rules.
`246Z00000X`	Anesthesiology	Anesthesiologists or CRNAs may be involved when sedation or monitored anesthesia care is provided for complex cases.
`364S00000X`	Nurse Anesthetist	CRNAs involved if anesthesia is furnished; rarely used for routine intravitreal injections.

ICD-10 Code	Description	Clinical Relevance
`H35.32`	Exudative age-related macular degeneration	A principal indication for posterior chamber/intravitreal pharmacologic injections to reduce neovascularization and macular edema.
`H36.0`	Diabetic retinopathy	Often accompanied by diabetic macular edema treated with posterior-segment injections of anti-VEGF or steroids.
`H35.81`	Retinal edema	Identifies macular or retinal edema that may be treated with intravitreal injection therapy.
`H35.89`	Other specified retinal disorders	Used for various retinal pathologies that may require posterior-segment injections.
`H44.1`	Endophthalmitis	Post-procedural complication; important to document if present and may necessitate additional therapeutic injections or surgery.
`H35.4`	Macular cyst, hole and pseudohole; macular cysts	Some macular pathologies are monitored or treated with intravitreal agents as part of management.
`H35.6`	Macular degeneration (unspecified)	Used when specific subtype is not specified but treatment with posterior injections is indicated.
`H59.14`	Postprocedural endophthalmitis of eye	Specific code for infection following an intraocular procedure, directly related to injection complications.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`67028`	Intravitreal injection of a pharmacologic agent (separate procedure)	Common alternative code billed by many practitioners for intravitreal injection of medication into the vitreous/posterior chamber; often reported instead of or alongside `0699T` depending on payer guidance and specific drug/technique.
`92083`	Extended ophthalmoscopy with retinography when performed; with interpretation and report	Performed for documentation of posterior segment status before or after injection when extended ophthalmoscopy or photographic documentation is needed.
`92134`	Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report; unilateral or bilateral	OCT of the macula is commonly performed before and after injection to document treatment response and guide retreatment.
`67036`	Vitrectomy, pars plana; with vitrectomy, for removal of vitreous opacities or membrane peeling	Performed in more invasive posterior segment surgical management when injections are insufficient or complications arise.
`99212`	Office or other outpatient visit for the evaluation and management of an established patient, typically 10 minutes	E/M visit code commonly used on the same day for evaluation and management associated with the injection visit when documentation meets E/M criteria.
`99070`	Supplies and materials (e.g., drugs, biologicals) provided by the physician	Used to report separately provided supplies when the payer allows; drug products themselves are often billed under J-codes rather than this supply code.

OpenPayer